Literature DB >> 12517756

The low sulfated chondroitin sulfate proteoglycans of human placenta have sulfate group-clustered domains that can efficiently bind Plasmodium falciparum-infected erythrocytes.

Rajeshwara N Achur1, Manojkumar Valiyaveettil, D Channe Gowda.   

Abstract

Plasmodium falciparum infection in pregnant women results in the chondroitin 4-sulfate-mediated adherence of the parasite-infected red blood cells (IRBCs) in the placenta, adversely affecting the health of the fetus and mother. We have previously shown that unusually low sulfated chondroitin sulfate proteoglycans (CSPGs) in the intervillous spaces of the placenta are the receptors for IRBC adhesion, which involves a chondroitin 4-sulfate motif consisting of six disaccharide moieties with approximately 30% 4-sulfated residues. However, it was puzzling how the placental CSPGs, which have only approximately 8% of the disaccharide 4-sulfated, could efficiently bind IRBCs. Thus, we undertook to determine the precise structural features of the CS chains of placental CSPGs that interact with IRBCs. We show that the placental CSPGs are a mixture of two major populations, which are similar by all criteria except differing in their sulfate contents; 2-3% and 9-14% of the disaccharide units of the CS chains are 4-sulfated, and the remainder are nonsulfated. The majority of the sulfate groups in the CSPGs are clustered in CS chain domains consisting of 6-14 repeating disaccharide units. While the sulfate-rich regions of the CS chains contain 20-28% 4-sulfated disaccharides, the other regions have little or no sulfate. Further, we find that the placental CSPGs are able to efficiently bind IRBCs due to the presence of 4-sulfated disaccharide clusters. The oligosaccharides corresponding to the sulfate-rich domains of the CS chains efficiently inhibited IRBC adhesion. Thus, our data demonstrate, for the first time, the unique distribution of sulfate groups in the CS chains of placental CSPGs and that these sulfate-clustered domains have the necessary structural elements for the efficient adhesion of IRBCs, although the CS chains have an overall low degree of sulfation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517756     DOI: 10.1074/jbc.M211015200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica.

Authors:  Reinhard Schwartz-Albiez; Yvonne Adams; Claus-W von der Lieth; Petra Mischnick; Katherine T Andrews; Michael Kirschfink
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

2.  Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression.

Authors:  Arivalagan Muthusamy; Rajeshwara N Achur; Manojkumar Valiyaveettil; John J Botti; Diane W Taylor; Rose F Leke; D Channe Gowda
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

3.  Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x is identified as a minimal chondroitin sulfate A-binding region.

Authors:  Kavita Singh; Rossitza K Gitti; Ababacar Diouf; Hong Zhou; D Channe Gowda; Kazutoyo Miura; Stanley A Ostazeski; Rick M Fairhurst; David N Garboczi; Carole A Long
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

4.  Targeted disruption of a ring-infected erythrocyte surface antigen (RESA)-like export protein gene in Plasmodium falciparum confers stable chondroitin 4-sulfate cytoadherence capacity.

Authors:  Suchi Goel; Arivalagan Muthusamy; Jun Miao; Liwang Cui; Ali Salanti; Elizabeth A Winzeler; D Channe Gowda
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

5.  Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy.

Authors:  Sean T Agbor-Enoh; Rajeshwara N Achur; Manojkumar Valiyaveettil; Rose Leke; Diane W Taylor; D Channe Gowda
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Reduced Arylsulfatase B activity in leukocytes from cystic fibrosis patients.

Authors:  Girish Sharma; Jenifer Burke; Sumit Bhattacharyya; Neha Sharma; Shivani Katyal; R Lucy Park; Joanne Tobacman
Journal:  Pediatr Pulmonol       Date:  2012-05-01

7.  Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides.

Authors:  Katherine T Andrews; Nicole Klatt; Yvonne Adams; Petra Mischnick; Reinhard Schwartz-Albiez
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.

Authors:  Kumar Kotlo; Sumit Bhattacharyya; Bo Yang; Leonid Feferman; Shah Tejaskumar; Robert Linhardt; Robert Danziger; Joanne K Tobacman
Journal:  Glycoconj J       Date:  2013-02-06       Impact factor: 2.916

9.  Plasmodium falciparum ookinetes require mosquito midgut chondroitin sulfate proteoglycans for cell invasion.

Authors:  Rhoel R Dinglasan; Aditi Alaganan; Anil K Ghosh; Akio Saito; Toin H van Kuppevelt; Marcelo Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

10.  Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: implications for mechanisms of action and resistance.

Authors:  Sumit Bhattacharyya; Kemal Solakyildirim; Zhenqing Zhang; Robert J Linhardt; Joanne K Tobacman
Journal:  Malar J       Date:  2009-12-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.